News

Idiopathic pulmonary fibrosis (IPF) is a chronic, persistent lung condition affecting over 32,000 people in the UK alone. This condition causes scarring of the lung tissue, leading to breathlessness and fatigue. 

Professor Anita Simonds, consultant in respiratory and sleep medicine, was awarded the European Respiratory Society’s (ERS) Yernault Lecture Award at its international congress last week.

A study carried out at the Trust, in partnership with Imperial College London, suggests that a treatment that is usually given to patients with dangerously high cholesterol could have a role to play in the treatment of refractory angina